环氧化酶-2特异性抑制剂——艾瑞昔布

杜小莉

中国药学杂志 ›› 2012, Vol. 47 ›› Issue (5) : 399.

PDF(459 KB)
PDF(459 KB)
中国药学杂志 ›› 2012, Vol. 47 ›› Issue (5) : 399.
新药评述

环氧化酶-2特异性抑制剂——艾瑞昔布

  • 杜小莉
作者信息 +

A Novel Selective COX-2 Inhibitor, Imrecoxib

Author information +
文章历史 +

引用本文

导出引用
杜小莉. 环氧化酶-2特异性抑制剂——艾瑞昔布[J]. 中国药学杂志, 2012, 47(5): 399
A Novel Selective COX-2 Inhibitor, Imrecoxib[J]. Chinese Pharmaceutical Journal, 2012, 47(5): 399

参考文献


[1] CHEN X H, BAI J Y, SHEN F, et al. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect [J]. Acta Pharmacol Sin(中国药理学报), 2004, 25(7): 927-931.
[2] LI Q, HUANG H H, DONG Y, et al. Investigation on the hydroxylation metabolism of imrecoxib in vitro by using recombinant human CYPs [J]. Acta Pharm Sin (药学学报), 2005, 40(10): 912-915.
[3] HUANG J L, GU J R, PAN Y F, et al. A multicenter ,double-blind and randomized controlled phase Ⅱ trial of imrecoxib in treatment of knee osteoarthritis[J]. Chin Pharm J(中国药学杂志), 2011,45(2):1740-1745.
PDF(459 KB)

Accesses

Citation

Detail

段落导航
相关文章

/